0001193125-20-120935 8-K 3 20200427 2.02 9.01 20200427 20200427 INTEVAC INC 0001001902 3559 943125814 DE 1231 8-K 34 000-26946 20819976 3560 BASSETT STREET SANTA CLARA CA 95054 4089869888 3560 BASSETT STREET SANTA CLARA CA 95054 8-K 1 d917443d8k.htm 8-K 8-K











Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

April 27, 2020

Date of Report (date of earliest event reported)




(Exact name of Registrant as specified in its charter)




State of Delaware   0-26946   94-3125814
(State or other jurisdiction   (Commission File Number)   (IRS Employer
of incorporation or organization)     Identification Number)

3560 Bassett Street

Santa Clara, CA 95054

(Address of principal executive offices)

(408) 986-9888

(Registrant’s telephone number, including area code)


(Former name or former address if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class





Name of each exchange on which registered

Common Stock ($0.001 par value)   IVAC   The Nasdaq Stock Market LLC (Nasdaq) Global Select

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐




Item 2.02.

Results of Operations and Financial Condition

On April 27, 2020, Intevac, Inc. issued a press release reporting its financial results for the three months ended March 28, 2020. A copy of the press release issued by the Company concerning the foregoing results is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.

The foregoing information is intended to be furnished under Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.


Item 9.01.

Financial Statements and Exhibits






Press Release.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.




Date: April 27, 2020




James Moniz

      Executive Vice President, Finance and Administration, Chief Financial Officer and Treasurer
EX-99.1 2 d917443dex991.htm EX-99.1 EX-99.1

Exhibit 99.1



   3560 Bassett Street, Santa Clara CA 95054    



James Moniz


Claire McAdams

Chief Financial Officer


Investor Relations

(408) 986-9888


(530) 265-9899


Santa Clara, Calif.—April 27, 2020—Intevac, Inc. (Nasdaq: IVAC) today reported financial results for the first quarter ended March 28, 2020.

“Today we are pleased to report stronger-than-expected results for the first quarter of 2020, especially in light of the stress placed on our operations and supply chain as a result of the COVID-19 global pandemic,” commented Wendell Blonigan, president and chief executive officer of Intevac. “During the quarter, we made several exciting announcements, including the debut of our branded DIAMOND DOG screen protectors, over $11 million of new contract awards in our Photonics business, and the finalization of the agreement to install a second INTEVAC VERTEX® evaluation system at a leading display cover glass manufacturer. Late in the quarter, our Santa Clara operations were impacted by the ‘shelter-in-place’ order that commenced in the Bay Area region on March 17th; however, with both our Thin-film Equipment (TFE) and Photonics businesses designated as within critical IT and Defense infrastructure sectors, Santa Clara factory operations resumed on March 30th, with employees working remotely wherever possible.

“The favorable results for Q1 were primarily driven by strong execution by our Photonics team, as they are doing an outstanding job delivering on the strong growth ramp expected for this business in 2020, which continues to proceed as planned. With Q1 TFE revenues aligned with our earlier forecasts, the team executed well, with both gross margin and operating expenses exceeding expectations in this challenging quarter.

“As a result of the global COVID-19 pandemic, specifically with activity in China and other hard-hit areas, we are experiencing delays in the progress of several TFE engineering programs, as well as the capacity expansion timelines we are driving in our 2020 plan. We anticipate these delays will elongate the sales process with our solar, display cover glass, and advanced semiconductor packaging growth initiatives in particular. Despite operating in this unprecedented environment, we remain confident in our strategy as we work through all the unknowns ahead. We have improved our balance sheet and operate on a very strong financial footing, and are confident we can continue to make solid progress toward our strategic growth objectives in this extremely challenging environment. I am also pleased to report that all of our employees around the world are well,” concluded Mr. Blonigan. “We are taking every precaution to protect and ensure the safety of our employees as they continue to perform essential work for the Company and the critical markets we serve.”


($ Millions, except per share amounts)    Q1 2020     Q1 2019  
     GAAP Results     Non-GAAP Results     GAAP Results     Non-GAAP Results  

Net Revenues

   $ 18.8     $ 18.8     $ 24.8     $ 24.8  

Operating Loss

   $ (1.1   $ (1.1   $ (2.0   $ (2.0

Net Loss

   $ (1.2   $ (1.2   $ (2.4   $ (2.4

Net Loss per Diluted Share

   $ (0.05   $ (0.05   $ (0.10   $ (0.10

Intevac’s non-GAAP adjusted results exclude the impact, where applicable, of changes in fair value of contingent consideration liabilities associated with business combinations. A reconciliation of the GAAP and non-GAAP adjusted results is provided in the financial table included in this release. See also “Use of Non-GAAP Financial Measures” section.

First Quarter 2020 Summary

The net loss was $1.2 million, or $0.05 per diluted share, compared to a net loss of $2.4 million, or $0.10 per diluted share in the first quarter of 2019.

Revenues were $18.8 million, including $8.0 million of TFE revenues and $10.9 million of Photonics revenues. TFE revenues consisted of upgrades, spares and service. Photonics revenues consisted of $5.9 million of product sales and $5.0 million of research and development contracts. In the first quarter of 2019, revenues were $24.8 million, including $18.9 million of TFE revenues which consisted of one 200 Lean® HDD system, four ENERGi® solar ion implant systems, upgrades, spares and service. Photonics revenues consisted of $2.7 million of product sales and $3.2 million of research and development contracts.

TFE gross margin improved to 44.0%, compared to 31.5% in the first quarter of 2019, primarily due to favorable product mix. Photonics gross margin improved to 42.8%, compared to 21.5% in the first quarter of 2019, primarily due to higher revenue levels and higher margins on both products and technology development contracts. Consolidated gross margin was 43.3%, compared to 29.2% in the first quarter of 2019.

R&D and SG&A expenses were $9.3 million, compared to $9.2 million in the first quarter of 2019.

Order backlog totaled $87.2 million on March 28, 2020, compared to $92.4 million on December 28, 2019 and $102.6 million on March 30, 2019. Backlog at both March 28, 2020 and December 28, 2019 included two 200 Lean HDD systems. Backlog at March 30, 2019 included five 200 Lean HDD systems and five ENERGi solar ion implant systems.

The Company ended the quarter with $43.2 million of total cash, restricted cash and investments and $95.5 million in tangible book value, defined as total stockholders’ equity, less intangible assets.

The Company repurchased 98,000 shares of common stock for a total of $393,000 during the first quarter. As of March 28, 2020, the Company had repurchased 5.1 million shares for $29.6 million out of the $40 million plan.

Use of Non-GAAP Financial Measures

Intevac’s non-GAAP results exclude the impact, where applicable, of changes in fair value of contingent consideration liabilities associated with business combinations. A reconciliation of the GAAP and non-GAAP results is provided in the financial tables included in this release.

Management uses non-GAAP results to evaluate the Company’s operating and financial performance in light of business objectives and for planning purposes. These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies. Intevac believes these measures enhance investors’ ability to review the Company’s business from the same perspective as the Company’s management and facilitate comparisons of this period’s results with prior periods. The presentation of this additional information should not be considered a substitute for results prepared in accordance with GAAP.

Conference Call Information

The Company will discuss its financial results and outlook in a conference call today at 1:30 p.m. PDT (4:30 p.m. EDT). To participate in the teleconference, please call toll-free (877) 407-0989 prior to the start time, and reference meeting number 13701589. For international callers, the dial-in number is +1 (201) 389-0921. You may also listen live via the Internet on the company’s investor relations website at ir.intevac.com. For those unable to attend live, an archived webcast of the call will be available at ir.intevac.com.

About Intevac

Intevac was founded in 1991 and has two businesses: Thin-film Equipment and Photonics.

In our Thin-film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties, such as the hard drive media, display cover panel, and solar photovoltaic markets we serve currently.

In our Photonics business, we are a recognized leading developer of advanced high-sensitivity digital sensors, cameras and systems that primarily serve the defense industry. We are the provider of integrated digital imaging systems for most U.S. military night vision programs.

For more information call 408-986-9888, or visit the Company’s website at www.intevac.com.

200 Lean®, INTEVAC MATRIX®, INTEVAC VERTEX®, and ENERGi® are registered trademarks and DIAMOND DOG, DiamondClad, VERTEX Marathon, and VERTEX Spectra are trademarks of Intevac, Inc.

Safe Harbor Statement

This press release includes statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Intevac claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms “may,” “believes,” “projects,” “expects,” or “anticipates,” and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: impacts related to the COVID 19 global pandemic, customer adoption of our products, future revenue growth potential for Photonics, and the future financial performance of Intevac. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the Company’s expectations. These risks include, but are not limited to: global economic impacts of COVID-19, supply chain constraints and disruptions related to COVID-19, technology risk and challenges achieving customer adoption and revenue recognition in Thin-film Equipment markets, and delays in Photonics programs, each of which could have a material impact on our business, our financial results, and the Company’s stock price. These risks and other factors are detailed in the Company’s periodic filings with the U.S. Securities and Exchange Commission.



(Unaudited, in thousands, except per share amounts)


     Three months ended  
     March 28,
     March 30,

Net revenues



   $ 7,962      $ 18,945  


     10,878        5,882  







Total net revenues

     18,840        24,827  

Gross profit

     8,156        7,239  

Gross margin



     44.0      31.5


     42.8      21.5








     43.3      29.2

Operating expenses


Research and development

     3,284        3,986  

Selling, general and administrative

     5,972        5,252  







Total operating expenses

     9,256        9,238  







Total operating loss

     (1,100      (1,999

Operating income (loss)



     (2,531      (603


     2,912        (640


     (1,481      (756







Total operating loss

     (1,100      (1,999

Interest and other income

     142        160  







Loss before provision for income taxes

     (958      (1,839

Provision for income taxes

     266        553  







Net loss

   $ (1,224    $ (2,392







Net loss per share


Basic and Diluted

   $ (0.05    $ (0.10

Weighted average common shares outstanding


Basic and Diluted

     23,483        22,855  



(In thousands, except par value)


     March 28,
       December 28,
     (Unaudited)        (see Note)  



Current assets


Cash, cash equivalents and short-term investments

   $ 37,891        $ 36,487  

Accounts receivable, net

     23,021          28,619  


     27,208          24,907  

Prepaid expenses and other current assets

     1,897          1,504  







Total current assets

     90,017          91,517  

Long-term investments

     4,549          5,537  

Restricted cash

     787          787  

Property, plant and equipment, net

     12,038          11,598  

Operating lease right-of-use-assets

     9,730          10,279  

Intangible assets, net

     120          274  

Deferred income tax and other long-term assets

     6,138          6,330  







Total assets

   $ 123,379        $ 126,322  









Current liabilities


Current operating lease liabilities

   $ 2,614        $ 2,524  

Accounts payable

     4,747          4,199  

Accrued payroll and related liabilities

     4,030          6,488  

Other accrued liabilities

     2,651          3,593  

Customer advances

     4,696          4,007  







Total current liabilities

     18,738          20,811  

Non-current liabilities


Non-current operating lease liabilities

     8,819          9,532  

Other long-term liabilities

     153          186  







Total non-current liabilities

     8,972          9,718  

Stockholders’ equity


Common stock ($0.001 par value)

     23          23  

Additional paid-in capital

     189,876          188,290  

Treasury stock, at cost

     (29,551        (29,158

Accumulated other comprehensive income

     331          424  

Accumulated deficit

     (65,010        (63,786







Total stockholders’ equity

     95,669          95,793  







Total liabilities and stockholders’ equity

   $ 123,379        $ 126,322  







Note: Amounts as of December 28, 2019 are derived from the December 28, 2019 audited consolidated financial statements.



(Unaudited, in thousands, except per share amounts)


     Three months ended  
     March 28,
       March 30,

Non-GAAP Loss from Operations


Reported operating loss (GAAP basis)

   $ (1,100      $ (1,999

Change in fair value of contingent consideration obligations1

     —            7  







Non-GAAP Operating Loss

   $ (1,100      $ (1,992

Non-GAAP Net Loss


Reported net loss (GAAP basis)

   $ (1,224      $ (2,392

Change in fair value of contingent consideration obligations1

     —            7  

Income tax effect of non-GAAP adjustments2

     —            —    







Non-GAAP Net Loss

   $ (1,224      $ (2,385

Non-GAAP Net Loss Per Share


Reported net loss per share (GAAP basis)

   $ (0.05      $ (0.10

Change in fair value of contingent consideration obligations1

     —            —    

Non-GAAP Net Loss Per Share

   $ (0.05      $ (0.10

Weighted average number of diluted shares outstanding

     23,483          22,855  



Results for the quarter ended March 30, 2019 include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010.


The amount represents the estimated income tax effect of the non-GAAP adjustments. The Company calculated the tax effect of non-GAAP adjustments by applying an applicable estimated jurisdictional tax rate to each specific non-GAAP item.

GRAPHIC 3 g917443g44e82.jpg GRAPHIC begin 644 g917443g44e82.jpg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end